FDA panel recommends approval of new facial filler

05/7/2013 | SkinAndAllergyNews.com

An FDA advisory panel recommended approval of Allergan's injectable Juvederm Voluma XC filler to treat age-related loss of midface volume. The product combines high- and low-molecular-weight hyaluronic acid and lidocaine and has a thick consistency intended for subcutaneous and supraperiosteal injection.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT